share_log
Breakings ·  May 22 20:02
Esperion Therapeutics Inc: European Commission Approved Label Update of Both Nilemdo and Nustendi
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment